More than 10 million people fall sick with tuberculosis (TB) every year. The disease remains the world’s biggest infectious disease killers with an estimated 1.25 million annual deaths. The disease is ...

During the frightening early weeks of the COVID-19 pandemic in March of 2020, Kiehl Sundt, of Sequim, Washington, became one of the first people on Earth to receive an experimental dose of Moderna’s ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Tufts University researchers’ approach uncovers how TB treatments can best work together at the cellular level to speed better cures Tuberculosis (TB) is the world’s deadliest infectious disease—and ...

TB, the Victorian superbug that features in the novels of Charles Dickens and many of his peers, is making a comeback in ...

Tuberculosis (TB) is the world's deadliest infectious disease—and one of the hardest to cure. Standard treatment requires a cocktail of multiple drugs over at least six months, and one in five ...

Recently, after years of pressure, advocates including author and philanthropist John Green scored victory against Johnson & Johnson over a patent on a key tuberculosis drug. The campaigners hope the ...

For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...

The shortage of tuberculosis drugs in Kisumu hospitals has put lives of patients at risk. The Standard has established that the situation has forced some patients who are unable to purchase the ...